Trade Floor
-
Crescendo enters collaboration to create cutting-edge oncology treatment
Cambridge-based Crescendo Biologics Ltd, the drug developer of novel, targeted T cell enhancing therapeutics has signed a pre-clinical collaboration... Read More
-
R4DAR hits accelerator and seeks growth funding
R4DAR Technologies Ltd, a Cambridge startup with a mission to improve the safety of all road users in the smart autonomous world, is one of 20... Read More
-
Medical alliance to advance technology push
Plextek Services and Design Momentum (DM) have announced a strategic partnership to develop scientific instruments and laboratory equipment for life... Read More
-
Healx fights rare disorder via new global alliance
Healx, the AI-powered technology business repurposing drugs to fight rare diseases, has forged a new global alliance that could hold significant... Read More
-
COVID-19 decontamination business acquired for £7m
East Anglia law firm Birketts has advised on the acquisition of DCUK FM, a leading asbestos removal business, from Marlowe plc for a sum of £7... Read More
-
Cambridge startup raising capital to transform drug target selection
An exciting young Cambridge company is raising fresh capital and seeking talented new recruits as it bids to revolutionise drug target selection.... Read More
-
Eagle in rudest of health after tie-up with hygiene specialist
UK-based global health and hygiene company RB is collaborating with Eagle Genomics in Cambridge in a research project designed to simplify... Read More
-
Cambridge startup inspires AI-led approach to cancer trials
Cambridge Cancer Genomics is leveraging its AI platform in a new partnership designed to more accurately target tumours in precision clinical trials... Read More
-
Arecor targets oncology and rare orphan diseases in US alliance
Cambridge biopharma business Arecor has extended its multi-product collaboration with a US-based clinical stage biotechnology company. Under the... Read More
-
Italian pioneer works with TTP to boost global health diagnostics
Technology hothouse TTP is at the heart of a European initiative to revolutionise in vitro diagnostic medical device (IVD) technology to boost... Read More
-
Calteq acquires cable specialist Blue Cube
Royston-based managed technologies provider, Calteq, has acquired Herts cable infrastructure company, Blue Cube Networks for an undisclosed sum.... Read More
-
Sea change with marine acquisition
East of England law firm Birketts has advised the owner of leading commercial maritime company Charity and Taylor on its sale to Aage Hempel Crame, a... Read More
-
Good Heavens: CEO sets up Australian acquisition
Norwich-based Epos Now, a leader in cloud POS, has entered into an agreement to acquire Epos Systems Pty, one of Australia’s leading POS providers... Read More
-
Heart and Seoul as Avacta launches Korean JV
Cambridge based BioMedTech business Avacta Group has joined forces with Daewoong Pharmaceutical to establish a significant joint venture in South... Read More
-
Healx and Boehringer battle rare neurological diseases
Cambridge-based Healx and German powerhouse Boehringer Ingelheim have joined forces to identify indications related to rare neurological diseases... Read More
-
Cambridge duo develop novel cell technology
Life sciences influencer Abcam and Cambridge neighbour SomaServe, a pharma service and specialist reagent business exploiting PolyNaut Technology,... Read More
-
Howes Percival acts in acquisition of Broads Tours
Howes Percival has acted for the purchaser in a deal that sees a much-loved Norfolk Broads company change hands. The Wroxham based company,... Read More
-
Abcodia and AstraZeneca China fight for earlier cancer detection
Cambridge UK business Abcodia, a leader in early cancer detection, has formed a strategic partnership with AstraZeneca China focusing on the early... Read More
-
Swell idea to combat heart failure risks seeks angel cash
A Cambridge HealthTech startup is using Artificial Intelligence to detect risks to heart failure patients in their homes. Heartfelt Technologies,... Read More
-
PhoreMost and Sentinel extend cancer collaboration
PhoreMost, the Cambridge biopharma company dedicated to drugging ‘undruggable’ disease targets, and Sentinel Oncology, have expanded a collaboration... Read More